Vanguard Group
BCAB icon

Vanguard Group’s BioAtla BCAB Stock Holding History

Vanguard Group’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.11M Hold
38,916
– – ﹤0.01% 3750
2025
Q3 		$1.34M Buy
38,916
+3,253
+9% +$75.1K ﹤0.01% 3699
2025
Q2 		$706K Sell
35,663
-697
-2% -$14.1K ﹤0.01% 3844
2025
Q1 		$631K Sell
36,360
-290
-0.8% -$6.2K ﹤0.01% 3829
2024
Q4 		$1.08M Sell
36,650
-1,055
-3% -$88.5K ﹤0.01% 3738
2024
Q3 		$3.32M Hold
37,705
– – ﹤0.01% 3410
2024
Q2 		$2.58M Sell
37,705
-4,276
-10% -$509K ﹤0.01% 3478
2024
Q1 		$7.22M Buy
41,981
+354
+0.9% +$44K ﹤0.01% 3135
2023
Q4 		$5.12M Sell
41,627
-419
-1% -$36.3K ﹤0.01% 3277
2023
Q3 		$3.57M Buy
42,046
+92
+0.2% +$11.7K ﹤0.01% 3387
2023
Q2 		$6.29M Buy
41,954
+3,486
+9% +$600K ﹤0.01% 3197
2023
Q1 		$5.15M Sell
38,468
-153
-0.4% -$27.6K ﹤0.01% 3295
2022
Q4 		$15.9M Buy
38,621
+10,456
+37% +$4.34M ﹤0.01% 2736
2022
Q3 		$10.8M Buy
28,165
+5,272
+23% +$1.73M ﹤0.01% 2920
2022
Q2 		$3.26M Sell
22,893
-8,233
-26% -$1.31M ﹤0.01% 3585
2022
Q1 		$7.78M Sell
31,126
-14,167
-31% -$5.93M ﹤0.01% 3279
2021
Q4 		$44.5M Buy
45,293
+3,513
+8% +$4.49M ﹤0.01% 2417
2021
Q3 		$61.5M Buy
41,780
+20,822
+99% +$40.6M ﹤0.01% 2243
2021
Q2 		$44.4M Buy
20,958
+877
+4% +$1.98M ﹤0.01% 2442
2021
Q1 		$51M Buy
20,081
+18,581
+1,239% +$47.6M ﹤0.01% 2305
2020
Q4 		$2.55M Buy
+1,500
New +$2.51M ﹤0.01% 3599

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group's BCAB Position: Q4 2025 in Review

Vanguard Group held its BioAtla (BCAB) position steady in Q4 2025 at 38,916 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3750.

Vanguard Group first reported a position in BCAB in Q4 2020 and has held it in 21 quarters since. The position peaked at $61.5M in Q3 2021. 41 funds tracked by Wall St. Rank hold BCAB as of Q4 2025.

  • Vanguard Group held 38,916 shares of BioAtla worth $1.11M as of Q4 2025.
  • Vanguard Group left its BioAtla share count unchanged in Q4 2025.
  • BioAtla made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3750 holding.
  • Vanguard Group first reported a position in BioAtla in Q4 2020 and has held it in 21 quarters since.
  • Vanguard Group's BioAtla position peaked at $61.5M in Q3 2021.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.